Citations (62)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Rajeev K. Singla, Xiaoyan Wang, Rohit Gundamaraju, Shikha Joon, Christos Tsagkaris, Sahar Behzad, Johra Khan, Rupesh Gautam, Rajat Goyal, Jaruporn Rakmai, Ankit Kumar Dubey, Jesus Simal-Gandara & Bairong Shen. (2023) Natural products derived from medicinal plants and microbes might act as a game-changer in breast cancer: a comprehensive review of preclinical and clinical studies. Critical Reviews in Food Science and Nutrition 63:33, pages 11880-11924.
Read now
Read now
Prabha Tiwari & Kaushala Prasad Mishra. (2023) Role of Plant-Derived Flavonoids in Cancer Treatment. Nutrition and Cancer 75:2, pages 430-449.
Read now
Read now
Amjad Hussain, Marie-Lise Bourguet-Kondracki, Farhad Hussain, Abdur Rauf, Muhammad Ibrahim, Muhammad Khalid, Hidayat Hussain, Javid Hussain, Iftikhar Ali, Anees Ahmed Khalil, Fahad A. Alhumaydhi, Muhammad Khan, Riaz Hussain & Kannan R. R. Rengasamy. (2022) The potential role of dietary plant ingredients against mammary cancer: a comprehensive review. Critical Reviews in Food Science and Nutrition 62:10, pages 2580-2605.
Read now
Read now
Articles from other publishers (59)
Qingran Guan, Jianshuo Su, Yinglan Li, Huaizhen Zhang, Zhuang Ding, Qingpeng Wang, Shilei Ji, Jun Han, Min Liu & Yanna Zhao. (2024) Near-Infrared Laser-Responsive Erythrocyte Membrane Camouflaged Nanoparticles for Chemo-Photodynamic Therapy of Breast Cancer. ACS Applied Nano Materials 7:11, pages 13785-13798.
Crossref
Crossref
Wenjun Xie, Huashui Li, Qiang Lin & Naizhuo Ke. (2024) Network Pharmacological Analysis and Experimental Validation of the
Effects of Silybin on Proliferation, Migration, and Immunotherapy of
Papillary Thyroid Cancer. Endocrine, Metabolic & Immune Disorders - Drug Targets 24:6, pages 672-690.
Crossref
Crossref
Niraj Kumar Singh & Bharat Bhushan. (2024) Preclinical Evidence-based Neuroprotective Potential of Silibinin. Current Drug Research Reviews 16:1, pages 43-56.
Crossref
Crossref
Chengling Fan, Shubin Yuan, Yuemei Zhang, Yinmei Nie, Li Xiang, Tianchao Luo, Qi Xi, Yaqin Zhang, Zixiang Gu, Peng Wang & Hongxia Zhou. (2024) Peroxiredoxin-1 as a molecular chaperone that regulates glutathione S-transferase P1 activity and drives mutidrug resistance in ovarian cancer cells. Biochemistry and Biophysics Reports 37, pages 101639.
Crossref
Crossref
Pantha Prodip Ray, Mohammad Ashraful Islam, Mohammad Safiqul Islam, Aixia Han, Peiwu Geng, Md. Abdul Aziz & Abdullah Al Mamun. (2024) A comprehensive evaluation of the therapeutic potential of silibinin: a ray of hope in cancer treatment. Frontiers in Pharmacology 15.
Crossref
Crossref
Priyanka Sharma, Khushi Gupta, Sumit Kumar Khandai, Sonia Malik & Suresh Thareja. (2024) Phytometabolites as modulators of breast cancer: a comprehensive review of mechanistic insights. Medical Oncology 41:2.
Crossref
Crossref
Alexey I. Kalinkin, Vladimir O. Sigin, Ekaterina B. Kuznetsova, Ekaterina O. Ignatova, Ilya I. Vinogradov, Maxim I. Vinogradov, Igor Y. Vinogradov, Dmitry V. Zaletaev, Marina V. Nemtsova, Sergey I. Kutsev, Alexander S. Tanas & Vladimir V. Strelnikov. (2023) Epigenomic Profiling Advises Therapeutic Potential of Leukotriene Receptor Inhibitors for a Subset of Triple-Negative Breast Tumors. International Journal of Molecular Sciences 24:24, pages 17343.
Crossref
Crossref
Asma A. Mokashi & Neela M. Bhatia. (2023) Bioactive Natural Products for Breast Cancer Chemoprevention and
Treatment. Current Bioactive Compounds 19:10.
Crossref
Crossref
Zahra Rezaei Harandi, Razieh Heidari & Somayeh Reiisi. (2023) Co-Delivery of Silymarin and Metformin Dual-Loaded in Mesoporous Silica Nanoparticles Synergistically Sensitizes Breast Cancer Cell Line to Mitoxantrone Chemotherapy. IEEE Transactions on NanoBioscience 22:4, pages 872-880.
Crossref
Crossref
Hemlata Bhardwaj, Neeru Vasudeva & Sunil Sharma. (2023) Possible Mechanism and Pharmacological Activities of a Flavolignan
Silibinin. Current Bioactive Compounds 19:7.
Crossref
Crossref
Cynthia Lizzie Lobo, Amitha Shetty, Manohar M, Akhilesh Dubey & Sally A. El-Zahaby. (2023) Non-systemic Approaches for Ductal Carcinoma In Situ: Exploring the Potential of Ultra-flexible Combisomes as a Novel Drug Delivery Strategy—a Review. AAPS PharmSciTech 24:5.
Crossref
Crossref
Pooja Chinnikrishnan, Ibrahim Abdel Aziz Ibrahim, Abdullah R. Alzahrani, Naiyer Shahzad, Prathibha Sivaprakasam & Ashok Kumar Pandurangan. (2023) The Role of Selective Flavonoids on Triple-Negative Breast Cancer: An Update. Separations 10:3, pages 207.
Crossref
Crossref
Sevda Jafari, Saba Heydarian, Raymond Lai, Elnaz Mehdizadeh Aghdam & Ommoleila Molavi. (2022) Silibinin induces immunogenic cell death in cancer cells and enhances the induced immunogenicity by chemotherapy. BioImpacts 13:1, pages 51-61.
Crossref
Crossref
Daping Fan, Yue Yang & Wei Zhang. (2022) A novel circ_MACF1/miR-942-5p/TGFBR2 axis regulates the functional behaviors and drug sensitivity in gefitinib-resistant non-small cell lung cancer cells. BMC Pulmonary Medicine 22:1.
Crossref
Crossref
Sevda JafariAtabak BakhshaeiMorteza Eskandani & Ommoleila Molavi. (2022) Silibinin-Loaded Nanostructured Lipid Carriers for Growth Inhibition of Cisplatin-Resistant Ovarian Cancer Cells. ASSAY and Drug Development Technologies 20:8, pages 339-348.
Crossref
Crossref
Mohammad Rasoul Samandari Bahraseman, Babak Khorsand, Keyvan Esmaeilzadeh-Salestani, Solmaz Sarhadi, Nima Hatami, Banafsheh Khaleghdoust & Evelin Loit. (2022) The use of integrated text mining and protein-protein interaction approach to evaluate the effects of combined chemotherapeutic and chemopreventive agents in cancer therapy. PLOS ONE 17:11, pages e0276458.
Crossref
Crossref
Anjali Takke & Pravin Shende. (2022) Potential of cyclodextrin in hybrid liposomes for improving the solubility, bioavailability and stability of silibinin. Chemical Papers 76:10, pages 6579-6589.
Crossref
Crossref
Sruthi Sritharan, Sampurna Guha, Snoopy Hazarika & Nageswaran Sivalingam. (2022) Meta analysis of bioactive compounds, miRNA, siRNA and cell death regulators as sensitizers to doxorubicin induced chemoresistance. Apoptosis 27:9-10, pages 622-646.
Crossref
Crossref
Aisha Nawaz, Sumera Zaib, Abrar Ahmad & Tanzeela Riaz. (2022)
Isolation and Characterization of a Flavonoid and a Neolignan from
Silybum marianum
: In‐vitro Cytotoxic Evaluation
. ChemistrySelect 7:15.
Crossref
Crossref
Gertrud-Alexandra PALTINEAN, Gheorghe Tomoaia, Levente-Zsolt RACZ, Aurora MOCANU & Maria Tomoaia-Cotisel. (2022) INTERACTION OF BIOACTIVE COMPOUNDS WITH CERAMIC MATERIALS – A REVIEW. Annals of the Academy of Romanian Scientists Series on Physics and Chemistry 7:2, pages 47-82.
Crossref
Crossref
Tomas Koltai & Larry Fliegel. (2022) Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions. Journal of Evidence-Based Integrative Medicine 27, pages 2515690X2110688.
Crossref
Crossref
Cláudia Pinto, Honorina Cidade, Madalena Pinto & Maria Elizabeth Tiritan. (2021) Chiral Flavonoids as Antitumor Agents. Pharmaceuticals 14:12, pages 1267.
Crossref
Crossref
Ruma Baksi, Rita Rana & Manish Nivsarkar. (2021) Chemopreventive potential of plant-derived epigenetic inhibitors silibinin and quercetin: an involvement of apoptotic signaling cascade modulation. Future Journal of Pharmaceutical Sciences 7:1.
Crossref
Crossref
Anjali Takke & Pravin Shende. (2021) Monodispersed magnetographene quantum dot nanocomposites for delivery of silibinin. Colloids and Surfaces A: Physicochemical and Engineering Aspects 628, pages 127349.
Crossref
Crossref
Raphael Serruya & Yehoshua Maor. (2021) Hair growth-promotion effects at the cellular level and antioxidant activity of the plant-based extract Phyllotex™. Heliyon 7:9, pages e07888.
Crossref
Crossref
Kimia Karami & Khatereh Anbari. (2021) Breast Cancer: A Review of Risk Factors and New Insights into Treatment. Current Cancer Therapy Reviews 17:3, pages 207-233.
Crossref
Crossref
Hardeep Singh Tuli, Sonam Mittal, Diwakar Aggarwal, Gaurav Parashar, Nidarshana Chaturvedi Parashar, Sushil Kumar Upadhyay, Tushar Singh Barwal, Aklank Jain, Ginpreet Kaur, Raj Savla, Katrin Sak, Manoj Kumar, Mehmet Varol, Ashif Iqubal & Anil Kumar Sharma. (2021) Path of Silibinin from diet to medicine: A dietary polyphenolic flavonoid having potential anti-cancer therapeutic significance. Seminars in Cancer Biology 73, pages 196-218.
Crossref
Crossref
Didem Şöhretoğlu, Randolph Arroo, Suat Sari & Shile Huang. 2021. Discovery and Development of Anti-Breast Cancer Agents from Natural Products. Discovery and Development of Anti-Breast Cancer Agents from Natural Products
147
196
.
Sidharth Mehan, Saloni Rahi, Shubham Upadhayay & Andleeb Khan. 2021. Polyphenols-based Nanotherapeutics for Cancer Management. Polyphenols-based Nanotherapeutics for Cancer Management
95
141
.
Qaisar Nawaz, Miguel Fuentes-Chandía, Varun Tharmalingam, Muhammad Atiq Ur Rehman, Aldo Leal-Egaña & Aldo R. Boccaccini. (2020) Silibinin releasing mesoporous bioactive glass nanoparticles with potential for breast cancer therapy. Ceramics International 46:18, pages 29111-29119.
Crossref
Crossref
Alexandra K. Tsaroucha, Georgios N. Korovesis, Georgia Valsami, Maria Lambropoulou, Vasileios Kollaras, Constatinos Anagnostopoulos, Nikolaos Kostomitsopoulos, Eleni Zerbini & Constantinos Simopoulos. (2020) Silibinin-hydroxypropyl-β-cyclodextrin (SLB-HP-β-CD) complex prevents apoptosis in liver and kidney after hepatic ischemia-reperfusion injury. Food and Chemical Toxicology 145, pages 111731.
Crossref
Crossref
Diana S. Antal, Florina Ardelean, Stefana Avram, Ioana Z. Pavel, Corina Danciu, Codruta Soica & Cristina Dehelean. (2020) Flavonolignans: One Step Further in the Broad-Spectrum Approach of Cancer. Anti-Cancer Agents in Medicinal Chemistry 20:15, pages 1817-1830.
Crossref
Crossref
Leïla Sarah Sellam, Roberta Zappasodi, Fayçal Chettibi, Djamel Djennaoui, Nadia Yahi-Ait Mesbah, Zine-Charaf Amir-Tidadini, Chafia Touil-Boukoffa, Wahiba Ouahioune, Taha Merghoub & Mehdi Bourouba. (2020) Silibinin down-regulates PD-L1 expression in nasopharyngeal carcinoma by interfering with tumor cell glycolytic metabolism. Archives of Biochemistry and Biophysics 690, pages 108479.
Crossref
Crossref
Daniela Ferreira Rodrigues, Ricardo Pires das Neves, Alexandra T. P. Carvalho, Maria Lourdes Bastos, Vera M. Costa & Félix Carvalho. (2020) In vitro mechanistic studies on α-amanitin and its putative antidotes. Archives of Toxicology 94:6, pages 2061-2078.
Crossref
Crossref
Dominique Delmas, Jianbo Xiao, Anne Vejux & Virginie Aires. (2020) Silymarin and Cancer: A Dual Strategy in Both in Chemoprevention and Chemosensitivity. Molecules 25:9, pages 2009.
Crossref
Crossref
Julieta Afonso, Lúcio L. Santos, Adhemar Longatto-Filho & Fátima Baltazar. (2020) Competitive glucose metabolism as a target to boost bladder cancer immunotherapy. Nature Reviews Urology 17:2, pages 77-106.
Crossref
Crossref
Teodora Costea, Oana Cezara Vlad, Luminita-Claudia Miclea, Constanta Ganea, János Szöllősi & Maria-Magdalena Mocanu. (2020) Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer. International Journal of Molecular Sciences 21:2, pages 401.
Crossref
Crossref
Suchisnigdha Datta, Priyanka Saha, Subhabrata Dey & Dona Sinha. 2020. Pharmacotherapeutic Botanicals for Cancer Chemoprevention. Pharmacotherapeutic Botanicals for Cancer Chemoprevention
67
119
.
Suma K. Pawar & Seetharamappa Jaldappagari. (2019) Intercalation of a flavonoid, silibinin into DNA base pairs: Experimental and theoretical approach. Journal of Molecular Recognition 33:1.
Crossref
Crossref
Ommoleila Molavi, Farshid Torkzaban, Sevda Jafari, Solmaz Asnaashari & Parina Asgharian. (2019) Chemical Compositions and Anti-Proliferative Activity of the Aerial Parts and Rhizomes of Squirting Cucumber, Cucurbitaceae. Jundishapur Journal of Natural Pharmaceutical Products 15:1.
Crossref
Crossref
Ashkan Hassankhani Rad, Farshid Asiaee, Sevda Jafari, Ali Shayanfar, Afsaneh Lavasanifar & Ommoleila Molavi. (2019) Poly(ethylene glycol)-poly(ε-caprolactone)-based micelles for solubilization and tumor-targeted delivery of silibinin. BioImpacts 10:2, pages 87-95.
Crossref
Crossref
Anjali Takke & Pravin Shende. (2019) Nanotherapeutic silibinin: An insight of phytomedicine in healthcare reformation. Nanomedicine: Nanotechnology, Biology and Medicine 21, pages 102057.
Crossref
Crossref
Somaye Mirzaaghaei, Ali M. Foroughmand, Ghasem Saki & Mohammad Shafiei. (2019) Combination of Epigallocatechin-3-gallate and Silibinin: A Novel Approach for Targeting Both Tumor and Endothelial Cells. ACS Omega 4:5, pages 8421-8430.
Crossref
Crossref
Shaheen Mahira, Nagavendra Kommineni, Gulam Mohammed Husain & Wahid Khan. (2019) Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: A new insight into nanomedicine based combinational chemotherapy for prostate cancer. Biomedicine & Pharmacotherapy 110, pages 803-817.
Crossref
Crossref
Nazanin Fathi, Elham Ahmadian, Shahriar Shahi, Leila Roshangar, Haroon Khan, Maryam Kouhsoltani, Solmaz Maleki Dizaj & Simin Sharifi. (2019) Role of vitamin D and vitamin D receptor (VDR) in oral cancer. Biomedicine & Pharmacotherapy 109, pages 391-401.
Crossref
Crossref
Kasi Pandima Devi. 2019. Nonvitamin and Nonmineral Nutritional Supplements. Nonvitamin and Nonmineral Nutritional Supplements
321
325
.
Madhumita Roy & Amitava DattaMadhumita Roy & Amitava Datta. 2019. Cancer Genetics and Therapeutics. Cancer Genetics and Therapeutics
139
164
.
Jana Juráňová, Juliette Aury-Landas, Karim Boumediene, Catherine Baugé, David Biedermann, Jitka Ulrichová & Jana Franková. (2018) Modulation of Skin Inflammatory Response by Active Components of Silymarin. Molecules 24:1, pages 123.
Crossref
Crossref
Seil Sohn, Chun Kee Chung, Jin Hyung Jung, Kyung Chul Lee, Jinhee Kim, Ung-Kyu Chang, Moon Jun Sohn & Sung Hwan Kim. (2018) Nationwide comparative study of synchronous and metachronous spine metastasis in the adult Korean population. Journal of Clinical Neuroscience 57, pages 33-37.
Crossref
Crossref
Nazanin Fathi, Golnaz Rashidi, Ali Khodadadi, Shahriar Shahi & Simin Sharifi. (2018) STAT3 and apoptosis challenges in cancer. International Journal of Biological Macromolecules 117, pages 993-1001.
Crossref
Crossref
Shahriar Shahi, Sepideh Zununi Vahed, Nazanin Fathi & Simin Sharifi. (2018) Polymerase chain reaction (PCR)-based methods: Promising molecular tools in dentistry. International Journal of Biological Macromolecules 117, pages 983-992.
Crossref
Crossref
Imran Hussain, Sana Waheed, Kashif A. Ahmad, John E. Pirog & Viqar Syed. (2018)
Scutellaria baicalensis
targets the hypoxia‐inducible factor‐1α and enhances cisplatin efficacy in ovarian cancer
. Journal of Cellular Biochemistry 119:9, pages 7515-7524.
Crossref
Crossref
Rinat Gamirov, Ludmila Komarova, Rustem Khasanov & Regina Gamirova. (2018) Early Diagnosis of Breast Cancer: Public Health and Mammographic Screening. BioNanoScience 8:1, pages 407-411.
Crossref
Crossref
Jiyeon Ham, Whasun Lim, Fuller W. Bazer & Gwonhwa Song. (2017) Silibinin stimluates apoptosis by inducing generation of ROS and ER stress in human choriocarcinoma cells. Journal of Cellular Physiology 233:2, pages 1638-1649.
Crossref
Crossref
Sarmistha Mitra & Raju Dash. (2018) Natural Products for the Management and Prevention of Breast Cancer. Evidence-Based Complementary and Alternative Medicine 2018, pages 1-23.
Crossref
Crossref
Muhammad Younas, Christophe Hano, Nathalie Giglioli-Guivarc'h & Bilal Haider Abbasi. (2018) Mechanistic evaluation of phytochemicals in breast cancer remedy: current understanding and future perspectives. RSC Advances 8:52, pages 29714-29744.
Crossref
Crossref
Arpit Dheeraj, Dhanir Tailor, Surya P. Singh & Rana P. Singh. 2018. Role of Nutraceuticals in Chemoresistance to Cancer. Role of Nutraceuticals in Chemoresistance to Cancer
199
220
.
Joaquim Bosch-Barrera, Bernardo Queralt & Javier A. Menendez. (2017) Targeting STAT3 with silibinin to improve cancer therapeutics. Cancer Treatment Reviews 58, pages 61-69.
Crossref
Crossref
Jung-Il Kang, Min-Kyoung Kim, Ji-Hyeok Lee, You-Jin Jeon, Eun-Kyoung Hwang, Young-Sang Koh, Jin-Won Hyun, Soon-Young Kwon, Eun-Sook Yoo & Hee-Kyoung Kang. (2017) Undariopsis peterseniana Promotes Hair Growth by the Activation of Wnt/β-Catenin and ERK Pathways. Marine Drugs 15:5, pages 130.
Crossref
Crossref